ABO blood groups and pancreatic cancer risk and survival: Results from the PANcreatic Disease ReseArch (PANDoRA) consortium

Oncology Reports

Volumn 29, Issue 4, 2013, Pages 1637-1644

  Rizzato, Cosmeri ^a   Campa, Daniele ^a   Pezzilli, Raffaele ^b   Soucek, Pavel ^c   Greenhalf, William ^d   Capurso, Gabriele ^e   Talar Wojnarowska, Renata ^f   Heller, Anette ^h   Jamroziak, Krzysztof ^g   Khaw, Kay Tee ⁱ   Key, Tim J ^j   Bambi, Franco ^k   Landi, Stefano ^l   Mohelnikova Duchonova, Beatrice ^c   Vodickova, Ludmila ^m   Büchler, Markus W ^h   Bugert, Peter ^h   Vodicka, Pavel ^m   Neoptolemos, John P ^d   Werner, Jens ^h   Hoheise, Jörg D ^k   Bauer, Andrea S ^a   Giese, Nathalia ^h   Canzian, Federico ^a   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^d National Institute for Health Research   (United Kingdom)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f Departments of 6Digestive Tract Diseases   (Japan)

^g MEDICAL UNIVERSITY OF LODZ   (Poland)

^h UNIVERSITY OF HEIDELBERG   (Germany)

ⁱ UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^j UNIVERSITY OF OXFORD   (United Kingdom)

^k UNIVERSITY OF FLORENCE   (Italy)

^l UNIVERSITY OF PISA   (Italy)

^m CHARLES UNIVERSITY   (Czech Republic)

more..

Author keywords

ABO; Cancer risk; Genetic susceptibility; Pancreatic cancer

Indexed keywords

GLYCOSYLTRANSFERASE;

ABO GENE; ADULT; AGED; ARTICLE; BLOOD GROUP ABO SYSTEM; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE; GENE LOCUS; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREAS CANCER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ABO BLOOD-GROUP SYSTEM; ALLELES; CARCINOMA, PANCREATIC DUCTAL; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GLYCOSYLTRANSFERASES; HUMANS; PANCREATIC NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84874721663     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2285     Document Type: Article

References (28)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010.
2. Anderson K, Mack T and Silverman D: Cancer of the pancreas. Oxford University Press, New York, NY, 2006.
3. Hassan MM, Bondy ML, Wolff RA, et al: Risk factors for pancreatic cancer: case-control study. Am J Gastroenterol 102: 2696-2707, 2007.
4. Jones S, Hruban RH, Kamiyama M, et al: Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science 324: 217, 2009.
5. Tischkowitz MD, Sabbaghian N, Hamel N, et al: Analysis of the gene coding for the BRCA2-interacting protein PALB2 in familial and sporadic pancreatic cancer. Gastroenterology 137: 1183-1186, 2009.
6. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, et al: Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet 41: 986-990, 2009.
7. Low SK, Kuchiba A, Zembutsu H, et al: Genome-wide associa¬tion study of pancreatic cancer in Japanese population. PloS One 5: e11824, 2010.
8. Petersen GM, Amundadottir L, Fuchs CS, et al: A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet 42: 224-228, 2010.
9. Wu C, Miao X, Huang L, et al: Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations. Nat Genet 44: 62-66, 2011.
10. Wolpin BM, Chan AT, Hartge P, et al: ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst 101: 424-431, 2009.
11. Wolpin BM, Kraft P, Gross M, et al: Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res 70: 1015-1023, 2010.
12. Wolpin BM, Kraft P, Xu M, et al: Variant ABO blood group alleles, secretor status and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium. Cancer Epidemiol Biomarkers Prev 19: 3140-3149, 2010.
13. Moran AP, Gupta A and Joshi L: Sweet-talk: role of host glyco¬sylation in bacterial pathogenesis of the gastrointestinal tract. Gut 60: 1412-1425, 2011.
14. Yip SP: Sequence variation at the human ABO locus. Ann Hum Genet 66: 1-27, 2002.
15. Ben Q, Wang K, Yuan Y and Li Z: Pancreatic cancer incidence and outcome in relation to ABO blood groups among Han Chinese patients: a case-control study. Int J Cancer 128: 1179 1186, 2011.
16. Dandona M, Gao F, Linehan DC and Wang-Gillam A: Re: ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst 102: 135-137, 2010.
17. Engin H, Bilir C, Ustun H and Gokmen A: ABO blood group and risk of pancreatic cancer in a Turkish population in Western Blacksea region. Asian Pac J Cancer Prev 13: 131-133, 2012.
18. Campa D, Rizzato C, Capurso G, et al: Genetic susceptibility to pancreatic cancer and its functional characterisation: The PANcreatic Disease ReseArch (PANDoRA) consortium. Dig Liver Dis: Nov 30, 2012 (Epub ahead of print). doi: 10.1016/j.dld.2012.09.014.
19. Rizzato C, Campa D, Giese N, et al: Pancreatic cancer suscepti¬bility loci and their role in survival. PloS One 6: e27921, 2011.
20. Day N, Oakes S, Luben R, et al: EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer 80 (Suppl 1): 95-103, 1999.
21. Davey GK, Spencer EA, Appleby PN, Allen NE, Knox KH and Key TJ: EPIC-Oxford: lifestyle characteristics and nutrient intakes in a cohort of 33 883 meat-eaters and 31 546 non meat-eaters in the UK. Public Health Nutr 6: 259-269, 2003.
22. Ferlay J, Parkin DM and Steliarova-Foucher E: Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46: 765-781, 2010.
23. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2008. CA Cancer J Clin 58: 71-96, 2008.
24. Hallouin F, Goupille C, le Cabellec M, Bara J and le Pendu J: Expression of A and H blood-group and of CD44 antigens during chemical rat colonic carcinogenesis. Glycoconj J 14: 801-808, 1997.
25. Hakomori S: Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer. Biochim Biophys Acta 1473: 247-266, 1999.
26. Hakomori S: Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines. Adv Exp Med Biol 491: 369-402, 2001.
27. Li D, Morris JS, Liu J, et al: Body mass index and risk, age of onset and survival in patients with pancreatic cancer. JAMA 301: 2553-2562, 2009.
28. Rahbari NN, Bork U, Hinz U, et al: AB0 blood group and prognosis in patients with pancreatic cancer. BMC Cancer 12: 319, 2012.